Difference between revisions of "Zhu YL, et al. Oncol. Rep. (2014) cited as Ref 691 in DOI: 10.1038/s41392-020-0110-5 (Q9954)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 32, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): Overexpression of CD133 enhances chemoresistance to 5-fluorouracil by activating the PI3K/Akt/p70S6K pathway in gastric cancer cells, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | Overexpression of CD133 enhances chemoresistance to 5-fluorouracil by activating the PI3K/Akt/p70S6K pathway in gastric cancer cells (English) | ||
| Property / title: Overexpression of CD133 enhances chemoresistance to 5-fluorouracil by activating the PI3K/Akt/p70S6K pathway in gastric cancer cells (English) / rank | |||
| + | Normal rank | ||
Revision as of 22:07, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Zhu YL, et al. Oncol. Rep. (2014) cited as Ref 691 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Zhu YL
0 references
2014
0 references
Oncol. Rep.
0 references
32
0 references
Overexpression of CD133 enhances chemoresistance to 5-fluorouracil by activating the PI3K/Akt/p70S6K pathway in gastric cancer cells (English)
0 references
